Absence of altered expression of optineurin in primary open angle glaucoma patients

Molecular Vision

Volumn 18, Issue , 2012, Pages 1421-1427

  Abu Amero, Khaled K ^a,c   Azad, Taif Anwar ^a   Spaeth, George L ^b   Myers, Jonathan ^b   Jay Katz, L ^b   Moster, Marlene ^b   Bosley, Thomas M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBULIN;

AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ETHNICITY; FEMALE; GENE; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; MALE; OPEN ANGLE GLAUCOMA; OPTN GENE; PRIORITY JOURNAL; PROMOTER REGION; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; BETA-GLOBULINS; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION; GLAUCOMA, OPEN-ANGLE; HUMANS; MALE; MIDDLE AGED; OPEN READING FRAMES; PATIENT SELECTION; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; TRANSCRIPTION FACTOR TFIIIA;

EID: 84863317073     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996; 80:389-93. [PMID: 8695555]
2. Quigley HA. Glaucoma. Lancet 2011; 377:1367-77. [PMID: 21453963]
3. Gherghel D, Hosking SL, Orgul S. Autonomic nervous system, circadian rhythms, and primary open-angle glaucoma. Surv Ophthalmol 2004; 49:491-508. [PMID: 15325194]
4. Llobet A, Gasull X, Gual A. Understanding trabecular meshwork physiology: a key to the control of intraocular pressure? News Physiol Sci 2003; 18:205-9. [PMID: 14500801]
5. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA 1991; 266:369-74. [PMID: 2056646]
6. Wilson MR, Hertzmark E, Walker AM, Childs-Shaw K, Epstein DL. A case-control study of risk factors in open angle glaucoma. Arch Ophthalmol 1987; 105:1066-71. [PMID: 3632414]
7. Morgan RW, Drance SM. Chronic open-angle glaucoma and ocular hypertension. An epidemiological study. Br J Ophthalmol 1975; 59:211-5. [PMID: 1138846]
8. Shin DH, Becker B, Kolker AE. Family history in primary openangle glaucoma. Arch Ophthalmol 1977; 95:598-600. [PMID: 849183]
9. Charliat G, Jolly D, Blanchard F. Genetic risk factor in primary open-angle glaucoma: a case-control study. Ophthalmic Epidemiol 1994; 1:131-8. [PMID: 8790619]
10. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Family history and risk of primary open angle glaucoma. The Baltimore Eye Survey. Arch Ophthalmol 1994; 112:69-73. [PMID: 8285897]
11. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90:262-7. [PMID: 16488940]
12. Abu-Amero KK, Morales J, Bosley TM. Mitochondrial abnormalities in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2006; 47:2533-41. [PMID: 16723467]
13. Sarfarazi M, Child A, Stoilova D, Brice G, Desai T, Trifan OC, Poinoosawmy D, Crick RP. Localization of the fourth locus (GLC1E) for adult-onset primary open-angle glaucoma to the 10p15-p14 region. Am J Hum Genet 1998; 62:641-52. [PMID: 9497264]
14. Rezaie T, Child A, Hitchings R, Brice G, Miller L, Coca-Prados M, Heon E, Krupin T, Ritch R, Kreutzer D, Crick RP, Sarfarazi M. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 2002; 295:1077-9. [PMID: 11834836]
15. Alward WL, Kwon YH, Kawase K, Craig JE, Hayreh SS, Johnson AT, Khanna CL, Yamamoto T, Mackey DA, Roos BR, Affatigato LM, Sheffield VC, Stone EM. Evaluation of optineurin sequence variations in 1,048 patients with openangle glaucoma. Am J Ophthalmol 2003; 136:904-10. [PMID: 14597044]
16. Aung T, Ebenezer ND, Brice G, Child AH, Prescott Q, Lehmann OJ, Hitchings RA, Bhattacharya SS. Prevalence of optineurin sequence variants in adult primary open angle glaucoma: implications for diagnostic testing. J Med Genet 2003; 40:e101. [PMID: 12920093]
17. Leung YF, Fan BJ, Lam DS, Lee WS, Tam PO, Chua JK, Tham CC, Lai JS, Fan DS, Pang CP. Different optineurin mutation pattern in primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2003; 44:3880-4. [PMID: 12939304]
18. Baird PN, Richardson AJ, Craig JE, Mackey DA, Rochtchina E, Mitchell P. Analysis of optineurin (OPTN) gene mutations in subjects with and without glaucoma: the Blue Mountains Eye Study. Clin Experiment Ophthalmol 2004; 32:518-22. [PMID: 15498064]
19. Mukhopadhyay A, Komatireddy S, Acharya M, Bhattacharjee A, Mandal AK, Thakur SK, Chandrasekhar G, Banerjee A, Thomas R, Chakrabarti S, Ray K. Evaluation of Optineurin as a candidate gene in Indian patients with primary open angle glaucoma. Mol Vis 2005; 11:792-7. [PMID: 16205626]
20. De Marco N, Buono M, Troise F, Diez-Roux G. Optineurin increases cell survival and translocates to the nucleus in a Rab8-dependent manner upon an apoptotic stimulus. J Biol Chem 2006; 281:16147-56. [PMID: 16569640]
21. Chalasani ML, Radha V, Gupta V, Agarwal N, Balasubramanian D, Swarup G. A glaucoma-associated mutant of optineurin selectively induces death of retinal ganglion cells which is inhibited by antioxidants. Invest Ophthalmol Vis Sci 2007; 48:1607-14. [PMID: 17389490]
22. Fenner BJ, Scannell M, Prehn JH. Identification of polyubiquitin binding proteins involved in NF-kappaB signaling using protein arrays. Biochim Biophys Acta 2009; 1794:1010-6. [PMID: 19285159]
23. Sudhakar C, Nagabhushana A, Jain N, Swarup G. NF-kappaB mediates tumor necrosis factor alpha-induced expression of optineurin, a negative regulator of NF-kappaB. PLoS ONE 2009; 4:e5114. [PMID: 19340308]
24. Park BC, Tibudan M, Samaraweera M, Shen X, Yue BY. Interaction between two glaucoma genes, optineurin and myocilin. Genes Cells 2007; 12:969-79. [PMID: 17663725]
25. Quigley HA. Glaucoma. Lancet 2011; 377:1367-77. [PMID: 21453963]
26. Bosley TM, Hellani A, Spaeth GL, Myers J, Katz LJ, Moster MR, Milcarek B, Abu-Amero KK. Down-regulation of OPA1 in patients with primary open angle glaucoma. Mol Vis 2011; 17:1074-9. [PMID: 21552501]
27. Abu-Amero KK, Jaber M, Hellani A, Bosley TM. Genomewide expression profile of LHON patients with the 11778 mutation. Br J Ophthalmol 2010; 94:256-9. [PMID: 19726426]
28. Sullivan PF, Fan C, Perou CM. Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet 2006; 141B:261-8. [PMID: 16526044]
29. Tang Y, Gilbert DL, Glauser TA, Hershey AD, Sharp FR. Blood gene expression profiling of neurologic diseases: a pilot microarray study. Arch Neurol 2005; 62:210-5. [PMID: 15710849]
30. Spaeth GL. Prognostic factors for progression of visual field damage in patients with normal-tension glaucoma. Jpn J Ophthalmol 2007; 51:156-7. [PMID: 17401633]
31. Eid TM, Spaeth GL, Bitterman A, Steinmann WC. Rate and amount of visual loss in 102 patients with open-angle glaucoma followed up for at least 15 years. Ophthalmology 2003; 110:900-7. [PMID: 12750087]
32. Bayer A, Harasymowycz P, Henderer JD, Steinmann WG, Spaeth GL. Validity of a new disk grading scale for estimating glaucomatous damage: correlation with visual field damage. Am J Ophthalmol 2002; 133:758-63. [PMID: 12036666]
33. Read RM, Spaeth G. The natural history of cup progression and some specific disc field correlations. Trans Am Acad Ophthalmol Otolaryngol 1974; 78:OP255-74. [PMID: 4825055]
34. Kim J, Dally LG, Ederer F, Gaasterland DE, VanVeldhuisen PC, Blackwell B, Sullivan EK, Prum B, Shafranov G, Beck A, Spaeth GL, Investigators A. The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations. Ophthalmology 2004; 111:2109-16. [PMID: 15522379]
35. Bustin SA, Beaulieu JF, Huggett J, Jaggi R, Kibenge FS, Olsvik PA, Penning LC, Toegel S. MIQE precis: Practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments. BMC Mol Biol 2010; 11:74. [PMID: 20858237]
36. Spaeth GL. Prognostic factors for progression of visual field damage in patients with normal-tension glaucoma. Jpn J Ophthalmol 2007; 51:156-7. [PMID: 17401633]
37. Allingham RR, Liu Y, Rhee DJ. The genetics of primary openangle glaucoma: a review. Exp Eye Res 2009; 88:837-44. [PMID: 19061886]
38. Liu Y, Munro D, Layfield D, Dellinger A, Walter J, Peterson K, Rickman CB, Allingham RR, Hauser MA. Serial analysis of gene expression (SAGE) in normal human trabecular meshwork. Mol Vis 2011; 17:885-93. [PMID: 21528004]
39. Pfeffer BA, DeWitt CA, Salvador-Silva M, Cavet ME, Lopez FJ, Ward KW. Reduced myocilin expression in cultured monkey trabecular meshwork cells induced by a selective glucocorticoid receptor agonist: comparison with steroids. Invest Ophthalmol Vis Sci 2010; 51:437-46. [PMID: 19696178]
40. Liton PB, Luna C, Challa P, Epstein DL, Gonzalez P. Genomewide expression profile of human trabecular meshwork cultured cells, nonglaucomatous and primary open angle glaucoma tissue. Mol Vis 2006; 12:774-90. [PMID: 16862071]
41. Coimbra RS, Voisin V, de Saizieu AB, Lindberg RL, Wittwer M, Leppert D, Leib SL. Gene expression in cortex and hippocampus during acute pneumococcal meningitis. BMC Biol 2006; 4:15. [PMID: 16749930]
42. Kurian SM, Le-Niculescu H, Patel SD, Bertram D, Davis J, Dike C, Yehyawi N, Lysaker P, Dustin J, Caligiuri M, Lohr J, Lahiri DK, Nurnberger JI Jr, Faraone SV, Geyer MA, Tsuang MT, Schork NJ, Salomon DR, Niculescu AB. Identification of blood biomarkers for psychosis using convergent functional genomics. Mol Psychiatry. 2011 [PMID: 19935739]
43. Saris CG, Horvath S, van Vught PW, van Es MA, Blauw HM, Fuller TF, Langfelder P, DeYoung J, Wokke JH, Veldink JH, van den Berg LH, Ophoff RA. Weighted gene co-expression network analysis of the peripheral blood from Amyotrophic Lateral Sclerosis patients. BMC Genomics 2009; 10:405. [PMID: 19712483]
44. Hu VW, Nguyen A, Kim KS, Steinberg ME, Sarachana T, Scully MA, Soldin SJ, Luu T, Lee NH. Gene expression profiling of lymphoblasts from autistic and nonaffected sib pairs: altered pathways in neuronal development and steroid biosynthesis. PLoS ONE 2009; 4:e5775. [PMID: 19492049]
45. Takahashi M, Hayashi H, Watanabe Y, Sawamura K, Fukui N, Watanabe J, Kitajima T, Yamanouchi Y, Iwata N, Mizukami K, Hori T, Shimoda K, Ujike H, Ozaki N, Iijima K, Takemura K, Aoshima H, Someya T. Diagnostic classification of schizophrenia by neural network analysis of blood-based gene expression signatures. Schizophrenia Research. [PMID: 20083392]
46. Paper W, Kroeber M, Heersink S, Stephan DA, Fuchshofer R, Russell P, Tamm ER. Elevated amounts of myocilin in the aqueous humor of transgenic mice cause significant changes in ocular gene expression. Exp Eye Res 2008; 87:257-67. [PMID: 18602390]
47. Ray K, Mookherjee S. Molecular complexity of primary open angle glaucoma: current concepts. J Genet 2009; 88:451-67. [PMID: 20090207]
48. del Toro D, Alberch J, Lazaro-Dieguez F, Martin-Ibanez R, Xifro X, Egea G, Canals JM. Mutant huntingtin impairs post-Golgi trafficking to lysosomes by delocalizing optineurin/ Rab8 complex from the Golgi apparatus. Mol Biol Cell 2009; 20:1478-92. [PMID: 19144827]
49. Fenner BJ, Scannell M, Prehn JH. Identification of polyubiquitin binding proteins involved in NF-kappaB signaling using protein arrays. Biochim Biophys Acta 2009; 1794:1010-6. [PMID: 19285159]
50. Park BC, Shen X, Samaraweera M, Yue BY. Studies of optineurin, a glaucoma gene: Golgi fragmentation and cell death from overexpression of wild-type and mutant optineurin in two ocular cell types. Am J Pathol 2006; 169:1976-89. [PMID: 17148662]
51. Park BC, Tibudan M, Samaraweera M, Shen X, Yue BY. Interaction between two glaucoma genes, optineurin and myocilin. Genes to Cells: Devoted to Molecular & Cellular Mechanisms 2007; 12:969-79. [PMID: 17663725]
52. Anborgh PH, Godin C, Pampillo M, Dhami GK, Dale LB, Cregan SP, Truant R, Ferguson SS. Inhibition of metabotropic glutamate receptor signaling by the huntingtin-binding protein optineurin. J Biol Chem 2005; 280:34840-8. [PMID: 16091361]